EO 14398, RFO, INV, non-commercial BOT
Active Awarded Last action
- Contract number
- 75N93020D00006
- Awardee
-
Bioqual, Inc. UEI CK9LGQ7EBNN8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 6 $9,026,719 obligated
Award facts
- Opportunity
-
- NIAIDDAIDNIHAI201800011 Solicitation number
- Combined order value
-
- $9,026,719 Current, with exercised options
- $9,871,062 Potential, with all options
- Last date to order 94% complete
- IDV ceiling 14% used
- $66,355,351.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases (NIAID) awarded an indefinite-delivery contract to Bioqual, Inc., with a ceiling value of $66,355,351, on April 1, 2020, as a multiple-award vehicle. The contract is not set-aside and carries an ultimate completion date of March 31, 2027.
Work is performed at Bioqual's facility in Rockville, Maryland, with one delivery order specifying performance in Potomac, Maryland. The SVEUS (Simian Vaccine Evaluation Units) program supports development and evaluation of non-human primate models for assessing countermeasures against infectious diseases, including vaccines and therapeutic candidates.
Recent delivery orders issued under this IDIQ include core administrative and technical support ($2,767,384.53, awarded April 1, 2020, completion March 31, 2027), maintenance of non-human primates in an ABSL2/3 facility ($1,405,182.43, awarded April 1, 2020, completion March 31, 2027), Study P215 ($1,887,979, awarded September 8, 2021, completion August 25, 2026), Study P210-A ($1,216,423, awarded May 16, 2022, completion April 30, 2025), Study P218 ($782,160.63, awarded September 27, 2022, completion June 4, 2024), and Study P221 ($1,999,460, awarded September 1, 2023, completion August 31, 2025). All delivery orders use cost-plus-fixed-fee pricing with no set-aside designation.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93020D00006?
75N93020D00006 was awarded to Bioqual, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2020.
How much is contract 75N93020D00006 worth?
Orders under 75N93020D00006 have obligated $9,026,719. Their combined potential value, with all options, is $9,871,062. 75N93020D00006's own ceiling is $66,355,351.
How many orders have been placed under contract 75N93020D00006?
6 orders have been placed under 75N93020D00006, the latest on September 1, 2023.
Who can order from contract 75N93020D00006?
75N93020D00006 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93020D00006 part of a contract vehicle?
Yes. 75N93020D00006 is part of Simian Vaccine Evaluation Units.
Was contract 75N93020D00006 competed?
The extent of competition for 75N93020D00006 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV